Pinansya
Pinansya
HomeDRREDDY • NSE
Dr Reddy's Laboratories Ltd
₹1,292.00
Hul 30, 3:59:49 PM GMT+5:30 · INR · NSE · Disclaimer
StockSegurong nakalista sa INMay headquarter sa IN
Nakaraang pagsara
₹1,299.80
Sakop ng araw
₹1,277.70 - ₹1,298.10
Sakop ng taon
₹1,020.00 - ₹1,421.49
Market cap
1.07T INR
Average na Volume
1.45M
P/E ratio
18.96
Dividend yield
0.62%
Primary exchange
NSE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(INR)Hun 2025Y/Y na pagbabago
Kita
85.45B11.37%
Gastos sa pagpapatakbo
31.15B9.57%
Net na kita
14.18B1.85%
Net profit margin
16.59-8.54%
Kita sa bawat share
17.021.94%
EBITDA
21.43B-1.36%
Aktuwal na % ng binabayarang buwis
25.99%
Kabuuang asset
Kabuuang sagutin
(INR)Hun 2025Y/Y na pagbabago
Cash at mga panandaliang investment
Kabuuang asset
Kabuuang sagutin
Kabuuang equity
Natitirang share
832.04M
Presyo para makapag-book
Return on assets
Return on capital
11.38%
Net change in cash
(INR)Hun 2025Y/Y na pagbabago
Net na kita
14.18B1.85%
Cash mula sa mga operasyon
Cash mula sa pag-invest
Cash mula sa financing
Net change in cash
Malayang cash flow
Tungkol
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology. Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to other less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. By 2007, Dr. Wikipedia
Itinatag
1984
Mga Empleyado
27,811
Tumuklas pa
Maaaring interesado ka sa
Nabuo ang listahang ito mula sa mga paghahanap kamakailan lang, mga sinubaybayang security, at iba pang aktibidad. Alamin pa

“As is” na ibinibigay ang lahat ng data para lang sa mga layunin sa personal na impormasyon, at hindi inilaan na maging payong pinansyal, ni hindi rin ito para sa mga layunin sa trading o investment, buwis, legal, accounting, o iba pang payo. Hindi tagapayo sa investment ang Google, ni hindi rin ito pinansyal na tagapayo at walang inihahayag na pananaw, rekomendasyon, o opinyon patungkol sa anumang kumpanyang kasama sa listahang ito o sa anumang seguridad na inisyu ng mga kumpanyang iyon. Konsultahin ang iyong broker o pampinansyal na kinatawan para ma-verify ang presyo bago magsagawa ng anumang trade. Matuto pa
Naghanap din ang mga tao ng
Search
I-clear ang paghahanap
Isara ang paghahanap
Mga app ng Google
Pangunahing menu